Member Log-in

I forgot my password

Not a Member? Register


Our resource library is a searchable collection of tools and documents related to various technical areas around the Gavi transition. The library consists of research articles, policy briefs, reports, guidebooks, country data, and other resources pertinent to Gavi transition or immunization programs generally. You can filter the resources by topic, type, or country. 

Some resources are available to LNCT members only and will require logging in to view. 

Results 1 -10 of 14

Re-evaluating the Potential Impact and Cost-effectiveness of Rotavirus Vaccination in 73 Gavi Countries: A Modelling Study

Background Previous studies have found rotavirus vaccination to be highly cost-effective in low-income countries. However, updated evidence is now available for several inputs (ie, rotavirus disease mortality rates, rotavirus age distributions, vaccine timeliness, and vaccine efficacy by duration of follow-up), new rotavirus vaccines have entered the market, vaccine prices have decreased, and cost-effectiveness thresholds have … Continued

WHO Guide for Standardization of Economic Evaluations of Immunization Programs

WHO has recently published a new edition of the guidance to meet the increased need to carry out immunization economic evaluations for decision making using the latest methodologies. This updated guide brings together the recommendations and guidance from many recent guidelines, tools and other documents on specific aspects of immunization and on specific vaccines. The … Continued

The Costs of Delivering Vaccines in Low- and Middle-income Countries: Findings from a Systematic Review

Abstract Information on immunization delivery costs (IDCs) is essential for better planning and budgeting for the sustainability and performance of national programs. However, delivery cost evidence is fragmented and of variable quality, making it difficult for policymakers, planners, and other stakeholders to understand and use. This study aimed to consolidate and summarize the evidence on … Continued

Sustaining Pneumococcal Vaccination After Transitioning from Gavi Support: A Modelling and Cost-effectiveness Study in Kenya

Background In 2009, Gavi, the World Bank, and donors launched the pneumococcal Advance Market Commitment, which helped countries access more affordable pneumococcal vaccines. As many low-income countries begin to reach the threshold at which countries transition from Gavi support to self-financing (3-year average gross national income per capita of US$1580), they will need to consider … Continued

Training Video: Applied Health Economics in Africa – Using Examples from Immunization

Using examples from immunizations, this Teaching Vaccine Economics Everywhere (TVEE) training video focuses on developing skills in economic evaluations, carrying out a cost effectiveness and budget impact analysis, and building local capacity in vaccine economics. The training was conducted at a 2019 AfHEA pre-congress session. View the TVEE training video in full.

Expenditures on Vaccine-preventable Disease Surveillance: Analysis and Evaluation of Comprehensive Multi-year Plans (cMYPs) for Immunization

Despite the importance of vaccine-preventable disease (VPD) surveillance, little is known about the costs of monitoring disease. Researchers used Comprehensive Multi-Year Plans for Immunization (cMYPs) – developed by countries following guidelines from the World Health Organization and United Nations Children’s Fund – to estimate expenditures on VPD surveillance at the country level in 2015 US … Continued

Poverty Reduction and Equity Benefits of Introducing or Scaling up Measles, Rotavirus and Pneumococcal Vaccines in Low-income and Middle-income Countries: A Modelling Study

Beyond their impact on health, vaccines can lead to large economic benefits. While most economic evaluations of vaccines have focused on the health impact of vaccines at a national scale, it is critical to understand how their impact is distributed along population subgroups. The team of researchers built a financial risk protection model to evaluate … Continued

The Equity Impact Vaccines May Have On Averting Deaths And Medical Impoverishment In Developing Countries

A team of researchers modeled the equity impact of lives saved and medical impoverishment averted from immunization over the period 2016-30 in 41 low and middle income countries (DHS survey availability determined which countries were selected for inclusion). Of our 15 LNCT member countries, data from Armenia, Ghana, Indonesia, Nigeria, and Timor-Leste were included in … Continued – Resource for Immunization Financing, Value, and Costing is a resource for organizations and individuals involved in the field of immunization economics. The site was originally created in 2015 as part of the EPIC project with funding from the Bill & Melinda Gates Foundation and has key collaborators from the Harvard T.H. Chan School of Public Health, Johns Hopkins University, ThinkWell, and … Continued

Immunization Costing and Financing: A Tool and User Guide for Comprehensive Multi-Year Plan (cMYP) – Update 2014

World Health Organization developed the cMYP Costing and Financing tool to complement the WHO-UNICEF comprehensive Multi-Year Plan guidelines (cMYP). The tool is intended to support strategic planning for immunization program costing and financing and makes it easy to estimate past costs and financing for immunization, to aid in making future projections of resources requirements and financing, … Continued

Choose a Language